Literature DB >> 9749644

The 1993 dengue 2 epidemic in North Queensland: a serosurvey and comparison of hemagglutination inhibition with an ELISA.

W J McBride1, H Mullner, J T LaBrooy, I Wronski.   

Abstract

An epidemic of dengue type 2 infection occurred in North Queensland during 1992 and 1993. A random serosurvey of 1,000 residents of a population that experienced this epidemic only during 1993 was conducted to determine the proportion of the population at risk for secondary infection in the event of another epidemic with a different serotype. The ability of an ELISA to detect prior exposure to the dengue virus was compared with the hemagglutination inhibition assay. Dengue 2 virus plaque-reduction neutralization assays were performed to evaluate the specificity of the antibody response. Antibodies to dengue virus, or closely related flaviviruses, were detected in 61.9%. Seroprevalence increased with age and correlated well with known previous epidemics in the region. The sensitivity and specificity of the ELISA was 99.2% and 96.2%, respectively. An estimated 26% of the population was infected during the 1993 epidemic.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9749644     DOI: 10.4269/ajtmh.1998.59.457

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania.

Authors:  Julian T Hertz; O Michael Munishi; Eng Eong Ooi; Shiqin Howe; Wen Yan Lim; Angelia Chow; Anne B Morrissey; John A Bartlett; Jecinta J Onyango; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; Duane J Gubler; John A Crump
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

2.  Seroepidemiology of Dengue virus in Mayotte, Indian Ocean, 2006.

Authors:  Daouda Sissoko; Khaled Ezzedine; Claude Giry; Amrat Moendandzé; Tinne Lernout; Eric D'Ortenzio; François Pettinelli; Denis Malvy
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

3.  Travel-related dengue virus infection, The Netherlands, 2006-2007.

Authors:  Gijs G G Baaten; Gerard J B Sonder; Hans L Zaaijer; Tom van Gool; Joan A P C M Kint; Anneke van den Hoek
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

Review 4.  Human Seroprevalence for Dengue, Ross River, and Barmah Forest viruses in Australia and the Pacific: A systematic review spanning seven decades.

Authors:  Eugene T Madzokere; Wei Qian; Julie A Webster; Daniel M H Walker; Elisa X Y Lim; David Harley; Lara J Herrero
Journal:  PLoS Negl Trop Dis       Date:  2022-04-29

5.  Dengue seroprevalence of healthy adults in Singapore: serosurvey among blood donors, 2009.

Authors:  Swee-Ling Low; Sally Lam; Wing-Yan Wong; Diana Teo; Lee-Ching Ng; Li-Kiang Tan
Journal:  Am J Trop Med Hyg       Date:  2015-05-26       Impact factor: 2.345

6.  Refining the global spatial limits of dengue virus transmission by evidence-based consensus.

Authors:  Oliver J Brady; Peter W Gething; Samir Bhatt; Jane P Messina; John S Brownstein; Anne G Hoen; Catherine L Moyes; Andrew W Farlow; Thomas W Scott; Simon I Hay
Journal:  PLoS Negl Trop Dis       Date:  2012-08-07

7.  Seroprevalence of dengue in American Samoa, 2010.

Authors:  Jennifer Duncombe; Colleen Lau; Philip Weinstein; John Aaskov; Michelle Rourke; Richard Grant; Archie Clements
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883

8.  Leptospirosis, diagnostic challenges, American Samoa.

Authors:  Colleen L Lau; John M DePasquale
Journal:  Emerg Infect Dis       Date:  2012-12       Impact factor: 6.883

9.  Spatial point analysis based on dengue surveys at household level in central Brazil.

Authors:  João B Siqueira-Junior; Ivan J Maciel; Christovam Barcellos; Wayner V Souza; Marilia S Carvalho; Nazareth E Nascimento; Renato M Oliveira; Otaliba Morais-Neto; Celina M T Martelli
Journal:  BMC Public Health       Date:  2008-10-20       Impact factor: 3.295

10.  Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection.

Authors:  Ying Xiu Toh; Victor Gan; Thavamalar Balakrishnan; Roland Zuest; Michael Poidinger; Solomonraj Wilson; Ramapraba Appanna; Tun Linn Thein; Adrian Kheng-Yeow Ong; Lee Ching Ng; Yee Sin Leo; Katja Fink
Journal:  Front Immunol       Date:  2014-08-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.